Ironwood Pharmaceuticals Provides First Quarter 2015 Investor Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Leerink Lowers PT after Ironwood Pharmaceuticals (IRWD) 1Q Results
May 6, 2015 11:00 AM EDTLeerink Partners reiterates a Market Perform rating on Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and lowers its price target to $16 (from $17) after weak 1Q sales. The Linzess profit share fell short of street expectations due to challenging sales, and seasonality, the analyst notes
Leerink analyst... More
Ironwood Pharma (IRWD) Reports Q1 Lost Per Share of 24c
May 5, 2015 5:07 PM EDTIronwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.24), may note compare the analyst estimate of ($0.23). Revenue for the quarter came in at $28.9 million versus the consensus estimate of $32.3 million.
For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.
... More


